This activity was planned with the goal of enabling participants to understand the latest trials and science in renal denervation (RDN) as an innovative approach to hypertension management. This activity is part of the Overcoming Challenges in Hypertension Management.  

Learner Objectives 
Upon completion of this activity, you should be able to: 

Important Dates
Date of Release: August 19, 2024
Term of Approval/Date of Expiration: August 19, 2025

Faculty
Taisei John Kobayashi, MD, FACC
Philadelphia, PA
Disclosure:
Consulting Fees/Honoraria: Medtronic, Endovascular Engineering, Recor Medical 

Acknowledgement
Educational grant support provided by: Medtronic